BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 26462893)

  • 21. Risk factors associated with venous thromboembolism in tuberculosis: A case control study.
    Nan GY; Fei H; Zhen W; Yun DT
    Clin Respir J; 2022 Dec; 16(12):835-841. PubMed ID: 36344481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of factor VIII/von Willebrand complex on the activated protein C-resistance phenotype and on the risk for venous thromboembolism in heterozygous carriers of the factor V Leiden mutation.
    De Mitrio V; Marino R; Scaraggi FA; Di Bari L; Giannoccaro F; Petronelli M; Ranieri P; Tannoia N; Schiraldi O
    Blood Coagul Fibrinolysis; 1999 Oct; 10(7):409-16. PubMed ID: 10695766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preoperative plasma D-dimer predicts 1-year survival in colorectal cancer patients with absence of venous thromboembolism (VTE): a prospective clinical cohort study.
    Stender MT; Larsen TB; Sørensen HT; Thorlacius-Ussing O
    J Thromb Haemost; 2012 Oct; 10(10):2027-31. PubMed ID: 22900573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated factor VIII in hereditary haemorrhagic telangiectasia (HHT): association with venous thromboembolism.
    Shovlin CL; Sulaiman NL; Govani FS; Jackson JE; Begbie ME
    Thromb Haemost; 2007 Nov; 98(5):1031-9. PubMed ID: 18000608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated levels of soluble fibrin in patients with venous thromboembolism.
    Tsuji A; Wada H; Matsumoto T; Abe Y; Ota S; Yamada N; Sugiyama T; Sudo A; Onishi K; Nakatani K; Uchida A; Ito M; Suzuki K; Nobori T
    Int J Hematol; 2008 Nov; 88(4):448-453. PubMed ID: 18836793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. D-dimer levels to screen for venous thromboembolism in patients with fractures caused by high-energy injuries.
    Niikura T; Sakai Y; Lee SY; Iwakura T; Nishida K; Kuroda R; Kurosaka M
    J Orthop Sci; 2015 Jul; 20(4):682-8. PubMed ID: 25797331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of a novel predictor of venous thromboembolic complications in inflammatory bowel disease with current predictors.
    Ohta Y; Arai M; Nakagawa T; Akizue N; Ishikawa K; Hamanaka S; Koseki H; Taida T; Okimoto K; Saito K; Yoshihama S; Maruoka D; Matsumura T; Katsuno T; Kato N
    J Gastroenterol Hepatol; 2019 May; 34(5):870-879. PubMed ID: 30225931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment.
    Lip GY; Lowe GD; Rumley A; Dunn FG
    Br Heart J; 1995 Jun; 73(6):527-33. PubMed ID: 7626351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of rosuvastatin on risk markers for venous thromboembolism in cancer.
    Ades S; Douce D; Holmes CE; Cory S; Prior S; Butenas S; Callas P; Cushman M
    J Thromb Haemost; 2018 Jun; 16(6):1099-1106. PubMed ID: 29575637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extensive evaluation of the instrumentation laboratory IL test D-Dimer immunoturbidimetric assay on the ACL 9000 determines the D-Dimer cutoff value for reliable exclusion of venous thromboembolism.
    Curtin N; Highe G; Harris M; Braunstein A; Demattia F; Coss L
    Lab Hematol; 2004; 10(2):88-94. PubMed ID: 15224764
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unfavourably altered plasma clot properties in patients with primary Raynaud's phenomenon: association with venous thromboembolism.
    Żuk J; Snarska-Drygalska A; Malinowski KP; Papuga-Szela E; Natorska J; Undas A
    J Thromb Thrombolysis; 2019 Feb; 47(2):248-254. PubMed ID: 30684190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Von Willebrand factor (vWF): marker of endothelial damage and thrombotic risk in COVID-19?
    Ladikou EE; Sivaloganathan H; Milne KM; Arter WE; Ramasamy R; Saad R; Stoneham SM; Philips B; Eziefula AC; Chevassut T
    Clin Med (Lond); 2020 Sep; 20(5):e178-e182. PubMed ID: 32694169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonvalvular atrial fibrillation: evidence for a prothrombotic state.
    Kahn SR; Solymoss S; Flegel KM
    CMAJ; 1997 Sep; 157(6):673-81. PubMed ID: 9307553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Haematological variables and risk of future venous thromboembolism in the British Regional Heart Study on men. Combined D-dimer and APTT as a predictive test for thromboembolism?
    Wannamethee SG; Papacosta O; Lennon L; Whincup PH; Rumley A; Lowe GDO
    Br J Haematol; 2022 Aug; 198(3):587-594. PubMed ID: 35655415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of a D-Dimer Protocol for Detection of Venous Thromboembolism.
    Karsy M; Azab MA; Harper J; Abou-Al-Shaar H; Guan J; Eli I; Brock AA; Ormond RD; Hosokawa PW; Gouripeddi R; Butcher R; Cole CD; Menacho ST; Couldwell WT
    World Neurosurg; 2020 Jan; 133():e774-e783. PubMed ID: 31605841
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Risk prediction of venous thromboembolism in non-small cell lung cancer patients based on COMPASS-CAT risk assessment model].
    Wang YF; Ma F; Liu BL; Yang K; Li JL; Yu L
    Zhonghua Zhong Liu Za Zhi; 2020 Apr; 42(4):340-345. PubMed ID: 32375452
    [No Abstract]   [Full Text] [Related]  

  • 37. Biomarkers for the diagnosis of venous thromboembolism: D-dimer, thrombin generation, procoagulant phospholipid and soluble P-selectin.
    Riva N; Vella K; Hickey K; Bertù L; Zammit D; Spiteri S; Kitchen S; Makris M; Ageno W; Gatt A
    J Clin Pathol; 2018 Nov; 71(11):1015-1022. PubMed ID: 30093507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasminogen activator inhibitor-1, thrombin-antithrombin, and prothrombin fragment F1+2 have higher diagnostic values than D-dimer for venous thromboembolism after TKA.
    Yang Y; Feng G; Yan J; Wu L; Wang F; Ding D; Wang H; Jin Q
    Clin Appl Thromb Hemost; 2022; 28():10760296221097383. PubMed ID: 35535394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. D-dimer, factor VIII coagulant activity, low-intensity warfarin and the risk of recurrent venous thromboembolism.
    Shrivastava S; Ridker PM; Glynn RJ; Goldhaber SZ; Moll S; Bounameaux H; Bauer KA; Kessler CM; Cushman M
    J Thromb Haemost; 2006 Jun; 4(6):1208-14. PubMed ID: 16706961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism.
    Douketis J; Tosetto A; Marcucci M; Baglin T; Cushman M; Eichinger S; Palareti G; Poli D; Tait RC; Iorio A
    Ann Intern Med; 2010 Oct; 153(8):523-31. PubMed ID: 20956709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.